AngioDynamics, University College London Hospital Launch International Multi-Center Study On Long Term Effects Of Treatment With NanoKnife System
Portfolio Pulse from Benzinga Newsdesk
AngioDynamics, in collaboration with University College London Hospital, has initiated an international multi-center study to investigate the long-term effects of treatment using the NanoKnife System. This study aims to provide valuable insights into the efficacy and safety of the NanoKnife technology.
October 23, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AngioDynamics has partnered with University College London Hospital to conduct a global study on the NanoKnife System's long-term effects. This could enhance the credibility and adoption of the NanoKnife technology.
The launch of an international study with a reputable institution like University College London Hospital could significantly enhance the credibility of AngioDynamics' NanoKnife System. Positive results from this study may lead to increased adoption and sales, potentially boosting AngioDynamics' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90